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INTRODUCTION
The management of colorectal cancer, especially that of
rectal cancer, has changed in many aspects during the last
few decades (1-3). Previous studies based on patients’ clini-
cal outcome and hospital data showed that a surgeon’s oper-
ation volume and the level of the hospital influenced the
treatment outcome, and the surgeon’s operation volume has
been suggested to be the most important contributing fac-
tor to the outcome (4-8). The volume-outcome association
is more pronounced in rectal cancer than in colon cancer due
to the high complexity of rectal surgery (6). Although the
difference in surgical procedures has been known to be the
most important influencing factor (6), more detailed differ-
ences have not been well evaluated. In the present study,
therefore, we attempted to unravel the differences of rectal
cancer management and then to compare the differences,
based on the surgeons and the hospitals. 
MATERIALS AND METHODS
Questionnaires describing preoperative evaluation, opera-
tive procedure, and postoperative surveillance in 39 major
categories were sent out to the members of the ‘Korean Soci-
ety of Coloproctology’, including the surgeons at 30 univer-
sity hospitals, in August 2004. The surgeons who operated
rectal cancer in their hospitals were requested to respond to
the questionnaires. Sixty responses were received during the
three months’ period. After the data were coded blindly into
the database, the results were compared according to the sur-
geon’s annual operation volume, the level of the hospital, and
the surgeon’s age. Statistical analyses were performed by chai-
square test using SPSS 11.0� (SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
Respondents
Thirty three respondents (55.0%) operated more than 50
rectal cancer cases (high-volume surgeons), and 37 respon-
dents (61.6%) worked at university hospitals or in other ter-
tiary care facilities (high-level hospitals) (Fig. 1). Twenty res-
pondents (33.3%) were 40-yr old or younger (young surge-
ons), and the respondents’ age was not significantly different
according to the surgeon’s operation volume or the level of
the hospital. 
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A Survey on the Impact of Operation Volume on Rectal Cancer 
Management
The rectal cancer management can be influenced by the surgeon’s practice and
the hospital. This study was to evaluate the differences according to the surgeon’s
operative volume and the level of the hospital. Questionnaires were sent out to the
members of the ‘Korean Society of Coloproctology’, and the responses were eval-
uated according to the surgeon’s operation volume, the surgeon’s age, and the
level of the hospital. Sixty responses were received during the three months’ peri-
od (from August to October 2004). Thirty three respondents (55%) operated more
than 50 cases of rectal cancer per year (high-volume surgeons), and 37 respon-
dents (61%) worked at university hospitals or tertiary care facilities (high-level hos-
pitals). The preoperative evaluation with endorectal ultrasonography (ERUS) was
significantly different according to the surgeon’s operation volume and the level of
the hospital, whereas magnetic resonance imaging and positron emission tomogra-
phy (PET) was significantly different only for the surgeon’s operation volume. The
preoperative radiation therapy was significantly different according to the surgeon’s
operation volume, the surgeon’s age, and the level of the hospital. However, there
was no significant difference found on the operative procedures or postoperative
surveillance. The preoperative loco-regional evaluation and the preoperative radi-
ation therapy could be considered as the factors that influence the volume-outcome
relationship in rectal cancer treatment.
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Preoperative evaluation
Preoperative rigid sigmoidoscopy was used routinely by
40.0% of the respondents and selectively by 36.6% of the
respondents, whereas 23.3% did not use the examination.
Colonoscopy, however, was performed routinely by 88.3%
of the respondents and selectively by 10.0% of the respon-
dents. The surgeons participated in colonoscopic examina-
tion alone or together with endoscopist at 50% of the respon-
dents’ hospitals. Only 21.7% of the respondents routinely
used barium enema, whereas 16.6% did not use this exami-
nation for preoperative evaluation. One respondent had a
limitation for usage of magnetic resonance imaging (MRI)
and positron emission tomography (PET) during their eval-
uation, while others performed the examinations without
limitation in their hospital or neighboring institution. Liver
imaging by computerized tomography (CT) was done by
96.7% of the respondents, and abdominal ultrasound was
additionally used by 30% of the respondents. Significant
differences were found in endorectal ultrasound (ERUS),
pelvic MRI, and 18F-fluorodeoxyglucose-PET: ERUS and
MRI were significantly different according to the surgeon’s
operation volume, and ERUS was also significantly different
according to the level of the hospital (Table 1). The selective
use of PET was significantly different according to the sur-
geon’s operation volume (Table 1). 
Preoperative radiation therapy
Preoperative radiation therapy was given fractionatedly in
4 to 6 weeks with the radiation dose ranging from 4,500 to
5,500 cGy. Forty six respondents (76.7%) performed preop-
erative radiation therapy, which was significant according to
the surgeon’s operation volume (90.9% of high-volume sur-
geons vs. 22.2% of low-volume surgeons), the level of the
hospital (89.1% of high-level hospitals vs. 56.5% of low-level
hospitals), and the surgeon’s age (95% of young surgeons vs.
67.5% of aged surgeons). As for the purpose of preoperative
radiation therapy, 80.4% of the 46 surgeons performed it
for the purpose of sphincter preservation. 
Operation
Total mesorectal excision (TME) was considered as the
principle in rectal cancer surgery by 96.6% of the respon-
dents, and 68.9% of them performed it only for mid and low
rectal cancer. Inferior mesenteric artery was ligated at its root
routinely by 26.6% and selectively by 68.3% of the respon-
dents. Rectal irrigation was performed before dividing below
a tumor by 81.6% of the respondents. During an operation,
2 cm of distal mucosal resection margin was considered as
safe by 62.0% of the respondents; and 1 cm or less by 29.3%
of the respondents. Paraaortic lymph node dissection was
performed routinely (5%), selectively (75%), or never (20%);
and lateral pelvic lymph node dissection was performed selec-
tively (93.3%) or never (6.6%). Coloanal anastomosis was
performed by 88.3% of the respondents, and the most pre-
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Fig. 1. Distribution of surgeons according to operation volume and
level of hospital. High-level hospital: university hospitals or tertiary
care facilities.
Low-level hospital
Volume of surgeon’s operation*
High (%) Low (%) p
Level of hospital�
High (%) Low (%) p
ERUS (n=60)
Always 11 (33.3) 3 (11.1) 8 (21.6) 6 (26.1)
Selectively 20 (40.7) 11 (40.7) <0.05 24 (64.9) 7 (30.4) <0.05
Never 2 (6.0) 13 (48.1) 5 (13.5) 10 (43.5)
MRI (n=59)
Selectively 24 (81.2) 9 (33.3) <0.05 24 (66.7) 11 (47.8) NS
Never 6 (18.8) 18 (66.7) 12 (33.3) 12 (52.2)
PET (n=59)
Selectively 16 (50.0) 4 (14.8) <0.05 14 (37.8) 6 (27.3) NS
Never 16 (50.0) 23 (85.2) 23 (62.2) 16 (72.7)
Table 1. Preoperative evaluation of rectal cancer according to the surgeon volume and the level of hospital: endorectal ultrasound
(ERUS), pelvic magnetic resonance imaging (MRI), and positron emission tomography (PET)
*High volume, who performs more than 50 operations of rectal cancer cases annually; 
�
High level, university hospitals and tertiary care facilities.
NS, not significant.
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ferred type was straight form (77.4%), J-pouch (15.1%) and
coloplasty (7.5%). Diverting stoma was performed routinely
(20.8%) or selectively (54.7%) during coloanal anastomosis,
however, 24.5% did not fashion diverting stoma during co-
loanal anastomosis. 
Operative procedures were not significantly different accor-
ding to the surgeon’s operation volume, the age, or the level
of the hospital. 
Postoperative management
Adjuvant chemotherapy was given by surgeons in 73.3%
of the respondents’ hospitals and by medical oncologists in
15.0% of the respondents’ hospitals. In 11.7% of the respon-
dents’ hospitals, chemotherapy was given by surgeons or
medical oncologists according to the patients. Postoperative
radiation therapy was given according to the stage: 21.6%
of the respondents routinely for T3N0 and 50.0% for T3N1
or T3N2. 
Carcinoembryonic antigen (CEA), abdominopelvic CT,
chest radiography, and colonoscopy were the main surveil-
lance tools after operation. There were no significant differ-
ences in the use of these tools according to the surgeon’s opera-
tion volume, the level of the hospital, or the surgeon’s age
(Table 2). Colonoscopy was performed annually (66%) or
biannually (28%) by 95% of the respondents for the fllow-
ing five years after operation. On the other hand, rigid sig-
moidoscope was used only by 43.3% of the respondents.
While the regular follow-up during the 5 yr postoperative
period was not significant, the regularity of follow up after
the initial 5 yr was significantly different showing 90% of
high-volume surgeons and 62% of low-volume surgeons
regularly performed it every one or two years (p<0.05). 
DISCUSSION
This study examined the differences in the rectal cancer
management by the surgeons in Korea. Rectal cancer has been
increasing in Korea, including 5,865 new cases reported in
2002. We strongly believe that more than 4000 operations
of rectal cancer cases are performed annually by the surgeons
who are included in this study. Therefore, considering resec-
tability (9), it is quite possible that this study covers more
than 70% of the rectal cancer operations in Korea.
The previous studies with oncologic outcome defined the
minimal volume for the experienced surgeon as one or two
operations per month, and the cutoff value of other studies
was about 15 cases or less (4-7). On the other hand, the stud-
ies with operative technique and outcome defined the cutoff
value as 50 or 75 operations per year (10-12). In this study,
the high operation volume was defined as more than 50 oper-
ations per year, and the majority of the surgeons (75%) oper-
ated more than 30 rectal cancer cases per year. It was possi-
ble that may surgeons with a low annual volume were not
included in this study.
Recent advances in the management of rectal cancer include
improved preoperative pelvic imaging, preoperative chemo-
radiation therapy, and improved rectal dissection (1, 2, 9, 13).
In the present study, significant differences have been found
in the preoperative evaluation with ERUS, MRI, and PET.
ERUS has been used for more than 20 yr and is known to
be accurate for the early stage. On the other hand, MRI is
more informative for the advanced stage and especially for
the mesorectal fascia which is important for keeping safe
circumferential resection margin during pelvic dissection
(14-17). PET is increasingly used for both local evaluation
and distant metastasis (18). In the present study, these pre-
operative evaluations have been found to be different accord-
ing to the surgeon’s operation volume, yet only ERUS has
been found to be significantly different according to the level
of the hospital. 
There were general agreements among the surgeons on
the operative procedure (more than 75% of the respondents
agreed): TME as the primary technique in rectal cancer sur-
gery; selective use of paraaortic and pelvic lymph node dis-
section; rectal irrigation; and coloanal anastomosis for sphinc-
ter preservation. On the other hand, the operation of upper
rectal cancer was controversial among the surgeons, which
was also noted in other studies (1, 19-21). Controversies on
diverting stoma for low rectal cancer operation (20, 22, 23)
were also noted in this study. Regardless of the general agree-
ments or the controversies, a significant difference was not
found according to the surgeon’s operation volume, the sur-
geon’s age, or the level of the hospital. 
Unlike the operative procedure, preoperative radiation
therapy was significantly different according to the surgeon’s
operation volume, the level of the hospital, and even the sur-
geon’s age, and it was the only significant factor according
to the surgeon’s age. Postoperative surveillance varied among
surgeons and was performed differently according to the
patient’s condition. Colonoscopy was frequently used rather
than sigmoidoscopy because of the comparable expense of
CT, computed tomography; CEA, carcinoembryonic antigen.
Surgeons (%)Examinations 
(per year) First 2 yr 3 to 5 yr
Abdominal CT
Once 42 81
Twice 52 12
Chest X-ray
Once 19 47
Twice or more 76 45
CEA
Once 1 26
Twice or more 98 70
Table 2. Postoperative surveillance until the 5th postoperative
year
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these medical examinations in Korea (24). The surveillance
system is affected by socioeconomical factors or by insurance
systems, which could be different according to the country.
These days, intensive surveillance is increasing for the early
detection of metastatic or recurrent diseases, and the exami-
nations were found more frequent in this study than in other
recommendation (25). 
This study was conducted by using a questionnaire, and
several limitations were present. The questionnaire was com-
pleted by the surgeons themselves and many low-volume
surgeons did not reply. All the complexities and the individ-
ualized treatments could not be assessed only by this ques-
tionnaire. The relationship between the surgeon’s actual prac-
tice and the clinical outcome could not be proved with this
study. Nevertheless, the surgeon’s intention and behavior
during the treatment of rectal cancer have accurately been
evaluated by this study, and the recent trends of rectal can-
cer operation were also revealed.
In conclusion, preoperative loco-regional evaluation was
significantly different according to the surgeon’s operation
volume, and preoperative radiation therapy was significant-
ly different according to the surgeon’s operation volume and
the level of the hospital. These results could be considered
as the factors to influence volume-outcome relationship in
rectal cancer treatment. 
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